Company intelligence / Profile preview

MML Medical

Heteren, Gelderland, Netherlands

Ownership: Private
Employees: ~20
Development stage: Other

Overview

MML Medical is a specialized distributor of medical devices and healthcare products based in the Netherlands, primarily serving the Benelux region. The company focuses on providing innovative solutions for compression therapy, wound care, and specialized surgical applications, representing international manufacturers such as Lympha Press and HIDREX. Their product portfolio includes pneumatic compression systems for lymphedema, iontophoresis devices for hyperhidrosis, and advanced wound dressing materials. MML Medical supports healthcare professionals and patients through product training, technical support, and direct supply of therapeutic equipment.

Therapeutic areas: OtherCardiovascularDermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Lympha PressHIDREXMepiformBio-Compression Systems

Beyond the preview

Go deeper on MML Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MML Medical.

Explore the full profile